GGrantIndex
← Leaderboards

Richard Joseph Johnson

Baylor College Of Medicine

$17,957,136
Attributed
$21,011,086
Total exposure
15
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200524
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$21,011,086 · 13
VA$0 · 2

By mechanism

R01$14,015,201 · 7
T32$2,854,108 · 2
RC4$2,271,441 · 1
R42$1,265,585 · 1
R21$421,058 · 1
R41$183,693 · 1

Most similar at Baylor College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Kidney

Research focus

KidneyMediatingLeadDiabetes MellitusHypertensionKidney DiseasesPathway InteractionsUric AcidBaseMetabolic SyndromeObesityInsightIntakeAutomobile DrivingRattusFructoseAnimalsEpidemicInsulin ResistancePlayChronic Kidney FailureDietEnzymesSugar

Grant awards (67)

Renal and Electrolyte Disease and Hypertension$310,248
T32 · FY2024 · DK
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology$629,682
R01 · FY2023 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$265,561
T32 · FY2023 · DK
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology$626,855
R01 · FY2022 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$263,850
T32 · FY2022 · DK
A Novel Mechanism for Sarcopenia in Chronic Kidney Disease$0
I01 · FY2022 · VA · contact PI
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology$632,187
R01 · FY2021 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$262,920
T32 · FY2021 · DK · contact PI
A Novel Mechanism for Sarcopenia in Chronic Kidney Disease$0
I01 · FY2021 · VA · contact PI
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology$635,398
R01 · FY2020 · DK · contact PI
A Novel Role for Vasopressin in Fructose-Induced Metabolic Syndrome$412,075
R01 · FY2020 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$260,716
T32 · FY2020 · DK · contact PI
A Novel Mechanism for Sarcopenia in Chronic Kidney Disease$0
I01 · FY2020 · VA · contact PI
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome$415,684
R01 · FY2019 · DK · contact PI
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity$206,585
R42 · FY2019 · DK · contact PI
A Novel Mechanism for Sarcopenia in Chronic Kidney Disease$0
I01 · FY2019 · VA · contact PI
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease$0
I01 · FY2019 · VA · contact PI
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity$769,627
R42 · FY2018 · DK · contact PI
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome$415,684
R01 · FY2018 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$293,270
T32 · FY2018 · DK · contact PI
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease$0
I01 · FY2018 · VA · contact PI
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome$415,684
R01 · FY2017 · DK · contact PI
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity$289,373
R42 · FY2017 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$219,093
T32 · FY2017 · DK · contact PI
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease$0
I01 · FY2017 · VA · contact PI
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome$401,470
R01 · FY2016 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$193,159
T32 · FY2016 · DK · contact PI
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease$0
I01 · FY2016 · VA · contact PI
Renal and Electrolyte Disease and Hypertension$274,652
T32 · FY2015 · DK · contact PI
Scientific Merit and Feasibility of Fructokinase Inhibiton for Obesity$183,693
R41 · FY2015 · DK · contact PI
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease$0
I01 · FY2015 · VA · contact PI
Renal and Electrolyte Disease and Hypertension$256,992
T32 · FY2014 · DK · contact PI
PROINFLAMMATORY ROLE OF URIC ACID IN LUNG DISEASE: NOVEL MODELS AND CLINICAL VALI$189,620
R21 · FY2014 · HL
PROINFLAMMATORY ROLE OF URIC ACID IN LUNG DISEASE: NOVEL MODELS AND CLINICAL VALI$231,438
R21 · FY2013 · HL
CD80 Expression on Podocytes and the Pathogenesis of Minimal Change Disease$173,383
R01 · FY2013 · DK · contact PI
CD80 Expression on Podocytes and the Pathogenesis of Minimal Change Disease$179,672
R01 · FY2012 · DK · contact PI
Role of Uric Acid in Cardiovascular and Renal Disease$397,498
R01 · FY2011 · HL · contact PI
CD80 Expression on Podocytes and the Pathogenesis of Minimal Change Disease$192,922
R01 · FY2011 · DK · contact PI
Development of inhibitors of AMP Deaminase Isoform 2 as a Mechanism for Treating$2,271,441
RC4 · FY2010 · DK · contact PI
Role of Uric Acid in Cardiovascular and Renal Disease$403,981
R01 · FY2010 · HL · contact PI
Role of Uric Acid in Cardiovascular and Renal Disease$416,015
R01 · FY2009 · HL · contact PI
Endothelial Cell in Progressive Renal Disease$292,323
R01 · FY2009 · DK · contact PI
Endothelial Cell in Progressive Renal Disease$80,986
R01 · FY2009 · DK · contact PI
Role of Uric Acid in Cardiovascular and Renal Disease$388,002
R01 · FY2008 · HL · contact PI
Endothelial Cell in Progressive Renal Disease$228,955
R01 · FY2008 · DK · contact PI
Endothelial Cell in Progressive Renal Disease$48,208
R01 · FY2008 · DK · contact PI
Pre & Post-Doctoral Training in Nephrology & Hypertension$33,511
T32 · FY2008 · DK · contact PI
Uric Acid and Hypertension in African-Americans$687,337
R01 · FY2007 · HL · contact PI
Endothelial Cell in Progressive Renal Disease$282,820
R01 · FY2007 · DK · contact PI
Pre & Post-Doctoral Training in Nephrology & Hypertension$186,625
T32 · FY2007 · DK · contact PI
Pre & Post-Doctoral Training in Nephrology & Hypertension$33,511
T32 · FY2007 · DK · contact PI
Uric Acid and Hypertension in African-Americans$704,160
R01 · FY2006 · HL · contact PI
Role of Uric Acid in Hypertension and Renal Disease$374,257
R01 · FY2006 · HL · contact PI
Endothelial Cell in Progressive Renal Disease$291,266
R01 · FY2006 · DK · contact PI
Uric Acid and Hypertension in African-Americans$708,790
R01 · FY2005 · HL
Role of Uric Acid in Hypertension and Renal Disease$375,156
R01 · FY2005 · HL
Endothelial Cell in Progressive Renal Disease$298,275
R01 · FY2005 · DK
Endothelial Cell in Progressive Renal Disease$400,125
R01 · FY2004 · DK
Role of Uric Acid in Hypertension and Renal Disease$393,877
R01 · FY2004 · HL
Endothelial Cell in Progressive Renal Disease$346,550
R01 · FY2003 · DK
Role of Uric Acid in Hypertension and Renal Disease$257,842
R01 · FY2003 · HL
Role of Uric Acid in Hypertension and Renal Disease$128,000
R01 · FY2003 · HL
Endothelial Cell in Progressive Renal Disease$75,250
R01 · FY2003 · DK
Endothelial Cell in Progressive Renal Disease$60,875
R01 · FY2003 · DK
Endothelial Cell in Progressive Renal Disease$413,875
R01 · FY2002 · DK
Role of Uric Acid in Hypertension and Renal Disease$390,663
R01 · FY2002 · HL
Endothelial Cell in Progressive Renal Disease$439,419
R01 · FY2001 · DK